Viewing Study NCT00942357

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:49 PM
Ignite Modification Date: 2026-01-08 @ 12:00 AM
Study NCT ID: NCT00942357
Status: UNKNOWN
Last Update Posted: 2021-10-19
First Post: 2009-07-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
Sponsor: Gynecologic Oncology Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Endometrial Clear Cell Adenocarcinoma View
None Endometrial Serous Adenocarcinoma View
None Stage IA Uterine Corpus Cancer AJCC v7 View
None Stage IB Uterine Corpus Cancer AJCC v7 View
None Stage II Uterine Corpus Cancer AJCC v7 View
None Stage IIIA Uterine Corpus Cancer AJCC v7 View
None Stage IIIB Uterine Corpus Cancer AJCC v7 View
None Stage IIIC Uterine Corpus Cancer AJCC v7 View
None Stage IVA Uterine Corpus Cancer AJCC v7 View
Keywords: